Patents Assigned to Quidel
  • Patent number: 10338084
    Abstract: Methods for preparing a sample for detection of an analyte of interest that is bound in vivo to a protein are provided. The method comprises providing a processing reagent comprising metaperiodate and contacting a sample suspected of comprising an analyte of interest associated with a protein with the processing reagent to form a mixture. The analyte of interest, if present in the sample (or mixture), is separated from its associated protein for detection of the analyte of interest. In one embodiment, the method is applied to samples for the detection of levels of vitamin D circulating in the blood. Samples are processed using the reagent disclosed herein to separate the analyte of interest, vitamin D or a metabolite thereof, from the vitamin D binding protein and/or albumin, for detection of the analyte separated from its binding protein(s).
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: July 2, 2019
    Assignee: Quidel Corporation
    Inventors: Richard L. Egan, Judson McFarland, Mark Renshaw
  • Patent number: 10281462
    Abstract: A system comprised of an apparatus and a test device is described. The test device and the apparatus are designed to interact to determine the presence or absence of an analyte of interest in a sample placed on the test device.
    Type: Grant
    Filed: November 4, 2015
    Date of Patent: May 7, 2019
    Assignee: Quidel Corporation
    Inventors: Richard L. Egan, Michael Jon Hale, Jhobe Steadman
  • Publication number: 20190118181
    Abstract: A combination of components in a capillary flow channel use capillary forces to passively control the movement of liquid samples within a microfluidic device. To detect a target, a liquid sample introduced to a proximal portion of a capillary channel of a microfluidic device moves by capillary action along the specific components of capillary channel.
    Type: Application
    Filed: March 17, 2017
    Publication date: April 25, 2019
    Applicant: Quidel Cardiovascular Inc.
    Inventors: Erik Mikael OLSSON, Austin DERFUS, Armando TOVAR, Justin DAVIDSON, Tuan DO, Paul CRIVELLI, Matthew WANG
  • Patent number: 10254288
    Abstract: A method for species-independent measurement of complement (C) activation in animals. The method comprises taking samples in the range of 3-100 microliter of anticoagulated blood, plasma or serum of an animal (specimen), mixing the specimen with a specificity converting protein matrix (SCM), mixing to the specimen/SCM mixture an activator of the C system (Act), incubating the specimen/SCM/Act mixture at a temperature between 36° C. to 38° C. for a time of 5-120 min and determining the production of one or more human proteins by ELISA or other analytical methods.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: April 9, 2019
    Assignee: Quidel Corporation
    Inventors: Marieluise Wippermann, Janos Szebeni
  • Patent number: 10168329
    Abstract: Methods, compositions and kits for detecting Group A streptococcus in a biological sample are described. More particularly, the present disclosure provides an immunoassay in which the specificity of detection of Group A streptococcus is enhanced by addition of N-acetyl-D-glucosamine. These methods, compositions and kits are useful in convenient, reliable and early diagnosis of streptococcal infection in a human subject.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: January 1, 2019
    Assignee: Quidel Corporation
    Inventors: Peter Yan-Guo Ren, Jason McClure, Kevin S. Richardson
  • Patent number: 10145842
    Abstract: A combination of capillary forces and gas pressure is used to control the movement of liquid samples within a microfluidic device. A liquid sample introduced to a proximal portion of a capillary channel of a microfluidic device moves by capillary action partway along the capillary channel. As the liquid sample moves, a pressure of a gas acting upon a distal gas-liquid interface of the liquid sample increases by an amount sufficient to stop further movement of the liquid sample. To initiate further movement of the liquid sample, a pump connected to a distal portion of the capillary channel decreases the pressure of the gas acting upon the distal gas-liquid interface of the liquid sample by an amount sufficient to permit the liquid sample to move by capillary action further along the capillary channel of the microfluidic device.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: December 4, 2018
    Assignee: Quidel Cardiovascular Inc.
    Inventors: William Patrick Coffey, Paul Michael Crivelli, Austin Matthew Derfus, Tuan Hoang Do, Remus Anders Brix Haupt, Emily Parker, Gregory Reneff, Armando Raul Tovar
  • Patent number: 10001482
    Abstract: More particularly, the present invention relates to a method for the detection of a target, e.g. pathogen in a human body fluid wherein a body fluid sample is collected with a swab member.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: June 19, 2018
    Assignee: Quidel Corporation
    Inventors: Franz Aberl, Marcus Scheibenzuber, Robert P. Sambursky, Robert W. VanDine, Jose S. Sambursky
  • Patent number: 9989466
    Abstract: Disclosed herein is a method for improving the precision of a test result from an instrument with an optical system that detects a signal. The method comprises including in the instrument a normalization target disposed directly or indirectly in the optical path of the optical system. Also disclosed are instruments comprising a normalization target, and systems comprising such an instrument and a test device that receives a sample suspected of containing an analyte.
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: June 5, 2018
    Assignee: Quidel Corporation
    Inventors: David Dickson Booker, Jhobe Steadman
  • Patent number: 9797019
    Abstract: The present invention relates generally to an assay for detecting and differentiating multiple analytes, if present, in a single fluid sample, including devices and methods therefore.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: October 24, 2017
    Assignee: Quidel Corporation
    Inventors: Paul Lambotte, Michael Cerrito, Cecille Ramirez
  • Patent number: 9562226
    Abstract: A device for extraction or isolation of an analyte, such as a nucleic acid, a protein, or a cell, from a sample, and in particular from a biological sample is described. Methods of using the device are also described.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: February 7, 2017
    Assignees: Quidel Corporation, Northwestern University
    Inventors: Ashley Danielle Cramer, Mark J. Fisher, Jacqueline R. Groves, David M. Kelso, Lawrence W. Markus, Zaheer Parpia, Kunal Sur, Tom Westberg
  • Patent number: 9404911
    Abstract: A laminated, integrated, analyte assay device and methods of using the device are described. The assay device is useful as an inexpensive, disposable assay device for detecting the presence and/or amount of a particular analyte in a body fluid or other sample.
    Type: Grant
    Filed: April 21, 2009
    Date of Patent: August 2, 2016
    Assignee: Quidel Corporation
    Inventors: Bruce Jacono, John C. Barry
  • Patent number: 9207181
    Abstract: A system comprised of an apparatus and a test device is described. The test device and the apparatus are designed to interact to determine the presence or absence of an analyte of interest in a sample placed on the test device.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: December 8, 2015
    Assignee: Quidel Corporation
    Inventors: Richard L. Egan, Michael Jon Hale, Jhobe Steadman
  • Patent number: 9207241
    Abstract: The present invention relates generally to an assay for detecting and differentiating multiple analytes, if present, in a single fluid sample, including devices and methods therefore.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: December 8, 2015
    Assignee: Quidel Corporation
    Inventors: Paul Lambotte, Michael Cerrito, Cecille Ramirez
  • Patent number: 8986937
    Abstract: The invention provides compositions and methods for detecting thyroid hormone blocking immunoglobulin (TBI). The invention's methods are sensitive and specific for TBI, and may be used for the dual detection of both TBI and TSI. The invention's compositions and methods are useful for the diagnosis of diseases that are associated with the presence of TBI and/or TSI, for monitoring the progress of disease and/or treatment regimens, therapeutics, vaccines, etc., and for assisting clinicians in making treatment decisions.
    Type: Grant
    Filed: September 9, 2011
    Date of Patent: March 24, 2015
    Assignee: Quidel Corporation
    Inventors: Yunsheng Li, Paul D. Olivo, Jaekyung Kim
  • Patent number: 8911956
    Abstract: Methods, compositions and kits for detecting the complement Factor B cleavage product Ba in a biological sample are described. These methods, compositions and kits are useful in convenient, reliable and early diagnosis of or ruling out pre-eclampsia in a pregnant human subject.
    Type: Grant
    Filed: February 18, 2014
    Date of Patent: December 16, 2014
    Assignee: Quidel Corporation
    Inventors: Nikol Lee De Forest, John Tamerius, Noah Nasser, Patrick Sexton
  • Publication number: 20140274770
    Abstract: The present disclosure is directed to PCR-based assays and compositions for use in molecular detection of viral, bacterial and parasitic infectious agents in body fluid or tissue samples, and in particular to multiplex assays, as well as to solid reagent compositions for use in such assays.
    Type: Application
    Filed: March 10, 2014
    Publication date: September 18, 2014
    Applicant: Quidel Corporation
    Inventor: Todd Denison Pack
  • Publication number: 20140255275
    Abstract: A packaging system with a dual chamber configuration is described. The packaging system is comprised of a primary chamber and a secondary chamber, where the primary chamber and the secondary chamber are in or capable of being in fluidic communication by a channel. The secondary chamber has an upper layer and a lower layer, wherein the lower layer is of a material that opens in response to an applied force that the upper layer is able to withstand, whereupon a fluid, preferably a liquid, in the primary chamber can be dispensed from the packaging system. In one embodiment, the packaging system is integrated with a planar cartridge having one or more chambers for processing a sample for detection of an analyte.
    Type: Application
    Filed: March 7, 2014
    Publication date: September 11, 2014
    Applicant: QUIDEL CORPORATION
    Inventors: John C. Barry, Peter Kroehl
  • Publication number: 20140170770
    Abstract: Methods, compositions and kits for detecting the complement Factor B cleavage product Ba in a biological sample are described. These methods, compositions and kits are useful in convenient, reliable and early diagnosis of or ruling out pre-eclampsia in a pregnant human subject.
    Type: Application
    Filed: February 18, 2014
    Publication date: June 19, 2014
    Applicant: Quidel Corporation
    Inventors: NIKOL LEE DE FOREST, John Tamerius, Noah Nasser, Patrick Sexton
  • Patent number: 8722426
    Abstract: The present invention relates generally to an assay for detecting and differentiating multiple analytes, if present, in a single fluid sample, including devices and methods therefore.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: May 13, 2014
    Assignee: Quidel Corporation
    Inventors: Paul Lambotte, Michael Cerrito, Cecille Ramirez
  • Publication number: 20140120552
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays. Such improvements are based upon the superior performance of assays comprising a chimeric TSH receptor in the presence of a glucocorticoid including, but not limited to, dexamethasone.
    Type: Application
    Filed: October 14, 2013
    Publication date: May 1, 2014
    Applicant: QUIDEL CORPORATION
    Inventors: LEONARD KOHN, JIM BROWN, DAVID SCHOLL, YUNSHENG LI, GIORGIO NAPOLITANO